GAMMA Investing’s Addex Therapeutics ADXN Stock Holding History

GAMMA Investing’s Portfolio ADXN Stock Details ADXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-81	Closed	-$509	–	4139
2026 Q1	$509	Hold	81	–	–	﹤0.01%	3947
2025 Q4	$625	Sell	81 -40	-33%	-$343	﹤0.01%	3885
2025 Q3	$1.14K	Hold	121	–	–	﹤0.01%	3588
2025 Q2	$1.14K	Sell	121 -1,072	-90%	-$8.67K	﹤0.01%	3513
2025 Q1	$8.76K	Buy	1,193 +182	+18%	+$1.41K	﹤0.01%	2812
2024 Q4	$7.08K	Buy	+1,011	New	+$9.21K	﹤0.01%	2764

Other funds holding ADXN

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

GAMMA Investing's ADXN Position: Q2 2026 in Review

GAMMA Investing sold out of Addex Therapeutics (ADXN) in Q2 2026, closing a stake of 81 shares — an estimated $509 sold.

GAMMA Investing first reported a position in ADXN in Q4 2024 and held it in 6 quarters. The position peaked at $8.76K in Q1 2025. 1 fund tracked by Wall St. Rank holds ADXN as of Q2 2026.

GAMMA Investing reported no remaining Addex Therapeutics position as of Q2 2026 after selling out during the quarter.
GAMMA Investing sold 81 Addex Therapeutics shares in Q2 2026, an estimated $509.
GAMMA Investing first reported a position in Addex Therapeutics in Q4 2024 and held it in 6 quarters.
GAMMA Investing's Addex Therapeutics position peaked at $8.76K in Q1 2025.
1 fund tracked by Wall St. Rank held Addex Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.